WebApr 13, 2024 · Radiotherapy on-chip: microfluidics for translational radiation oncology - Lab on a Chip (RSC Publishing) The clinical importance of radiotherapy in the treatment of … WebMay 10, 2024 · This trial is for people whose anal cancer is bigger than 4 cm or has spread to the lymph nodes (locally advanced). It is comparing standard with higher doses of chemoradiotherapy. Cancer Research UK supports this trial. More about this trial Who can enter Trial design Hospital visits Side effects Location Recruitment start: 13/01/2024
Radiopharmaceutical therapy in cancer: clinical advances
WebJan 27, 2015 · The total radiotherapy dose, number of fractions, and overall treatment time was administered according to local practice in every centre. However, we provided a guideline for dose fractionation of 40–50 Gy (2·66–2·00 Gy per fraction in 15–25 fractions) over 3–5 weeks at megavoltage irradiation to the breast. CHHiP is a phase III, multicentre, randomised controlled trial to see whether hypofractionated radiotherapy schedules (fewer fractions in higher doses) for localised prostate cancer could improve the therapeutic ratio by either improving tumour control or reducing normal tissue side effects. A total of … See more The five-year outcomes of CHHiP were first presented at the NCRI Cancer Conference 2015 and published in Lancet Oncology in June 2016. The ICR prepared a press releaseto … See more Chief Investigator: Professor David Dearnaley, The Royal Marsden NHS Foundation Trust ICR-CTSU Scientific Lead: Dr Emma Hall … See more Dearnaley D, Syndikus I, Mossop H, Khoo V, Birtle A, Bloomfield D, Graham J, Kirkbride P, Logue J, Malik Z, Money-Kyrle J, O'Sullivan JM, Panades M, Parker P, Patterson H, Scrase … See more small plates garden city
Hypofractionated Radiation Therapy for Localized Prostate Cancer: …
WebOct 4, 2024 · The CompARE Trial examines alternative regimens for escalating treatment of intermediate and high-risk oropharyngeal cancer in an adult patient population. The aim is to assess whether escalated radiotherapy, adding surgery or immunotherapy will improve overall survival and quality of life in these patients. Study Design Go to WebNov 7, 2024 · Recent development in radiation biology has revealed potent immunogenic properties of radiotherapy in cancer treatments. However, antitumor immune effects of radiotherapy are limited by the concomitant induction of radiation-dependent immunosuppressive effects. In the growing era of immunotherapy, combining … WebFeb 3, 2024 · The Alliance trial (NCCTG-N09C6) provided initial support for the use of a doxepin rinse for reducing mouth pain from radiation-induced mucositis in patients with head and neck cancer compared with placebo. 31 A follow-up study by the same investigators, Alliance A221304, compared a doxepin mouthwash or diphenhydramine-lidocaine … small plates eltham menu